logo logo


Entering into a dangerous battle
The military-installed Thai government is entering into a risky new battle with farmer’s groups and the anti-FTA movement by pressing ahead with the Thai-Japan free trade agreement. Thousands of farmers, environmental activists and medical patients now plan to stage a mass protest next month against the government’s pro-FTA policy.
Coup-installed govt seeks Japan’s approval via rushed trade pact
Despite an earlier announcement that all signing and negotiating of free trade agreements would be halted, the government of Gen Surayud Chulanont bit its tongue yet again, with the issuing of a cabinet resolution on Feb 20 stating its readiness to go ahead with the Japan-Thailand Economic Partnership Agreement (JTEPA).
KoA No FTA Newsletter #2
Farmers release animals in protest, 500 attend all-night vigil; KoA protest delegation holds all-night vigil, congressional briefing in DC; Limiting access to healthcare: FTA and pharmaceuticals
Malaysia Attorney-General defends generic medicines before UN rights body
Malaysia’s Attorney-General Tan Sri Abdul Gani has publicly stated his country’s stand "that generic drugs should not be restricted in any manner". Implying that a US-Malaysia FTA could result in more expensive drugs, he said that Malaysia is not going to negotiate on this issue, and added “we are providing the drugs for free.”
FTA kills! Stop negotiations with USA now!
It was an uncommon sight at the Bangunan Rawatan Utama, Universiti Malaya Medical Centre this morning, when 30-over anti US-Malaysia FTA coalition members suddenly gathered holding banners and placards at the outpatient unit lobby.
Oriental medical doctors resist FTA
Seoul’s move to open its market for oriental medicine has set off a fierce protest from local doctors who are concerned about increased competition in an already saturated market.
Harmonisation of TRIPS-plus IPR policies and potential impacts on technological capability: A case study of the pharmaceutical industry in Thailand
This study examines the impacts of TRIPS-plus rules on pharmaceutical patents as enshrined in US FTAs by looking at the case of Thailand.
Fears FTA brings in contaminated blood
Road crash victims and haemophiliacs were at risk of contracting blood-borne diseases such as HIV under the Australia-United States Free Trade Agreement (FTA), an academic warned today.
US advises developing country FTA partners not to follow WHO IP plan
Developing countries that have free trade agreements (FTAs) with the United States received an email in the form of a “démarche” from the US government before the 4-8 December 2006 meeting of the WHO Intergovernmental Working Group on Public Health, Innovation and Intellectual Property Rights saying that it had become apparent that the WHO was trying to go beyond its competency and address issues which could have impact on the scope and effect of FTAs.
Free trade deal may fast track nanotech
Australia may be forced to rush through inadequately tested and unsafe medical nanotherapies because of its free trade agreement with the US, a health technology regulation expert says.
CPTech hosts post-election FTA strategy session
Last Thursday at CPTech a packed audience and 8 panelists discussed strategies for addressing the access to medicine implications of bilateral free trade agreements (FTAs) between the US and other countries.
FTA drug talks in Seoul
Korea and the United States plan to hold talks next week on drug policy issues surrounding an envisioned bilateral free trade agreement (FTA).
US makes proposal on FTA screen quota issue: sources
With the fourth round of talks underway for a proposed free trade agreement (FTA), the US has reportedly made a proposal regarding protections currently in place on the South Korean film industry.
Internal memo shows Health Minister obstacle to FTA
South Korea tried to cut a deal with the United States to break the stalemate over their bilateral free trade agreement (FTA) talks but an internal dispute nixed the attempt.
Korea demands recognition for generic drugs
A Korea-US Free Trade Agreement (FTA) for pharmaceuticals is likely to speed up in the fourth round of the FTA talks, which will begin place Monday on Cheju Island.
Data exclusivity regulations in India
New Indian data exclusivity patenting regulations will severely hinder generic AIDS drugs manufacturing in India, and thus less people will have access to AIDS therapy globally. The world’s poor overwhelmingly make up this population with lack of access. Because of this, moral human rights and distributive justice approaches should compel India to take an equity-oriented approach in access to AIDS medicines and reject data exclusivity regulations currently under discussion.
US FTA may cost drug industry $1.2 billion: gov’t
A proposed free trade agreement with the United States is expected to cost as much as 1 trillion won (US$1.2 billion) in damage to the South Korean pharmaceutical industry if the US proposal for the deal is accepted, the South Korean government said.
Aids activists bring patent-drug fight to US
The Thai Network of People Living with HIV/Aids will launch the country’s first campaign abroad against the Thai-US free-trade agreement (FTA) from tomorrow to October 29 in US cities, including San Francisco, New York, Washington and Chicago.
Playing our own game
Sripai Noonsee was in despair after her latest attempt to find a job at an electronics factory at Bang Kadee Industrial Estate ended in failure like so many others. She has been jobless for many months.
Dominican pharma reiterates US demands exceed DR-CAFTA stipulations
The Dominican Association of Pharmaceutical Industries denounced yesterday as “abusive demands” the requirements recently posed by the United States Trade Representative, prior to implementing the Free Trade Agreement (DR-CAFTA).